University of Texas Houston - Division of Rheumatology and Clinical Immunogenetics

Houston, Texas 77030

1 studies enrolling now · 5 studies all time

What they study most

Acute Interstitial Pneumonitis, Cryptogenic Organizing Pneumonia, Desquamative Interstitial Pneumonia, Idiopathic Interstitial Pneumonia, Idiopathic Lymphoid Interstitial Pneumonia, Idiopathic Pleuroparenchymal Fibroelastosis, Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Interstitial Lung Disease Due to Systemic Disease, Pulmonary Arterial Hypertension, Pulmonary Hypertension, Raynaud Phenomenon Secondary to Systemic Sclerosis

Studies at this site

• Platform Clinical Study for Conquering Scleroderma — Recruiting now
• Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension RANGER — Stopped early
• Bardoxolone Methyl Evaluation in Patients With Pulmonary Hypertension (PH) - LARIAT — Completed
• Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 2) — Completed
• Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis (Phase 3) — Completed